Krishna Suri
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Natural Compounds in Disease Treatment
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Plant-derived Lignans Synthesis and Bioactivity 1
-
- Pharmacological Effects of Natural Compounds 1
- Ginger and Zingiberaceae research 1
- Inflammatory mediators and NSAID effects 1
- Co-authors
- Christian Celia (3 shared papers)Joy Wolfram (3 shared papers)Mauro Ferrari (3 shared papers)Haifa Shen (3 shared papers)Massimo Fresta (3 shared papers)Sarang Bani (5 shared papers)Yuliang Zhao (2 shared papers)Naresh K. Satti (3 shared papers)
- Journals
- Cytokine (1 paper)Pharmacological Research (1 paper)Current Drug Delivery (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)Evidence-based Complementary and Alternative Medicine (1 paper)
- Partner nations
- IndiaItalyUnited States
In The Last Decade
Krishna Suri
9 papers receiving 327 citations
Peers
Comparison fields: 5 of 75
- Biomaterials 94
- Complementary and alternative medicine 41
- Pharmacology 31
- Toxicology 12
- Pharmaceutical Science 21
Countries citing papers authored by Krishna Suri
This map shows the geographic impact of Krishna Suri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Suri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Suri more than expected).
Fields of papers citing papers by Krishna Suri
This network shows the impact of papers produced by Krishna Suri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Suri. The network helps show where Krishna Suri may publish in the future.
Co-authors
The 25 scholars most cited alongside Krishna Suri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 100 | |
| 2 | 2014 | 67 | |
| 3 | 2006 | 57 | |
| 4 | 2016 | 45 | |
| 5 | 2009 | 23 | |
| 6 | 2009 | 17 | |
| 7 | 2007 | 15 | |
| 8 | 2009 | 12 | |
| 9 | Ameliorating effects of aqueous fraction of Bidens pilosa against acute and chronic inflammation with reference to changes in proinflammatory mediators and T cells. | 2011 | 1 |
About Krishna Suri
Krishna Suri is a scholar working on Molecular Biology, Pharmacology, Oncology, Biomaterials and Pharmacology, having authored 9 papers that have together received 337 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (2 papers), Chemotherapy-induced organ toxicity mitigation (1 paper), Glycosylation and Glycoproteins Research (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Ginger and Zingiberaceae research (1 paper), Plant-derived Lignans Synthesis and Bioactivity (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Biomaterials (94 citations), Complementary and alternative medicine (41 citations), Pharmacology (31 citations), Toxicology (12 citations) and Pharmaceutical Science (21 citations). Krishna Suri has collaborated with scholars based in India, Italy and United States. Frequent co-authors include Christian Celia, Joy Wolfram, Mauro Ferrari, Haifa Shen, Massimo Fresta, Sarang Bani, Yuliang Zhao, Naresh K. Satti, Ghulam N. Qazi and Jianliang Shen. Their work appears in journals such as Cytokine, Pharmacological Research, Current Drug Delivery, Colloids and Surfaces B Biointerfaces and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.